Composition and method of treating hepatitis C

Details Composition and method of treating hepatitis C Composition and method of treating hepatitis C

1993-11-04

1998-12-15

Woodward, Michael P.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

4241981, 514 2, 514885, 514894, A61K 3818, A61K 3819

Patent

active

058496963

ABSTRACT:
Compositions and methods of use for treating hepatitis C virus-infected mammals are disclosed. The compositions include one or more thymosins alone or in combination with one or more interferons. Methods of treatment include use of thymosins alone, or together, or sequentially with interferon.

REFERENCES:
European Search Report dated Dec. 15, 1992.
Eichberg, et al., "Effect of Thymosin . . . Hepatitis B Carriers.", Chemical Abstracts, vol. 106, No. 15, Apr. 1987, Abstract No. 117943h pp. 487-488.
"Thymosin Treatment of Chronic Active hepatitis B (CAHB)," Mutchnick et al Hepatology, vol. 10, No. 575 (1989).
"Treatment of Chronic Woodchuck Hepatitis Virus Infection," Korba, Hepatology, vol. 12, p. 880 (1990).
"Thymosin Treatment of Chronic Active Hepatitis D . . . ," Mutchnick et al. Hepatology, vol. 8, No. 5, p. 1270 (1988).
Alter et al., "Treatment of Hepatitis C", The New England Journal of Medicine, 321: 1538-1540 (1989).
Davis et al., Treatment of Chronic Hepatitis C with Interferon, The New England Journal of Medicine, 321: 1501-1506 (1989).
Farci et al., "A Long-Term Study of Hepatitis C Virus . . . Non-A, Non-B Hepatitis," The New England Journal of Medicine, 325: 98-104 (1991).
Bisceolie, et al., "Recombinant Interferon Alfa Therapy . . . Hepatitis C," The New England Journal of Medicine, 321: 1506-1510 (1989).
Caldwell & Blendis "Hepatitis C: Wolf in Sheep's Cloething-Sometimes," Gastroenterology Journal Club, pp. 9-12, Apr. 1991.
Albert, "Alpha Interferon Treatment of Chronic Hepatitis C," Gastroenterolgy Journal Club, pp. 2-8, Apr. 1991.
Marcellin et al., "Recombinant Human Alpha-Inteferon . . . , " Hepatology, 393-398, (1991).
Kuo, G., et al., Science, 244:362-4 (1989).
Alter , H. J., in Zuckerman, A.J. ed., Viral Hepatitis and Liver Disease, Allen K. Liss, New York, 1988, pp. 537-542.
Kortez, R.L., et al., Gastroenterology, 88:1251-54 (1985).
Pappas, S.C., J. Med. Virol., 15:1-9 (1985).
Stokes, P., et al., Gastroenterology, 92:1783 Abstract (1987).
Hoofnagle, J.H. et al., New England Journal of Medicine, 315:1575-78 (1986).
Thomson, J., Lancet, 1:539-41 (1987).
Kiyosawa, K., et al., in Zuckerman, A., ed., Viral Hepatitis and Liver Disease, Allen K. Liss, NY, 1983 pp. 895-897.
Hoofnagle, J.H. et al., Sem. Liver Dis., 9:259-263 (1985).
Low, T.L.K., et al., Thymosing: Structure, Function and Therapeutic Application:, Thymus, 6:27-42 (1984).
Goldstein, et al., Proc. Nat'l Acad. Sci. (USA), 69:1800-1803 (1972).
Wetzel, R. et al., Biochemistry, 19:6096-6104 (1980).
Low, T.L.K., et al., J. Biol. Chem. , 254:981-6 (1979).
Schulof, R.S., et al., in The Lymphocyte, allen J. Liss Inc., NY, 1981, pp. 191-215.
Koutab, N.M. et al., Immunopharm., 16:97-105 (1988).
Favilli, C. et al., Cancer Immunol. Immunother., 20:189-92 (1985).
Marshall, G.D., et al., J. Immunol., 126:741-4 (1981).
Mutchnick, M.G., et al., Clin. Immunol. Immunopathol., 23:626-33 (1982).
Sztein, M.B., et al., Proc. Nat'l Acad. Sci. (USA) , 83:6107-6111 (1986).
Serrate, S.A., et al., J. Immunol., 1939:233-43 (1987).
Baxevanis, C.N., et al., Immunopharm. 13:133-41 (1987).
Svedersky, L.P., Eur. J. Immunol., 12:244-7 (1982).
Goldstein, A.L., et al., Transp. Proc. 9:1141 (1977).
Cohen, M.H., et al., J. Amer. Med. Assoc., 241: 1813-15 (1979).
Schulof, R.S., et al., J. Biol. Response Modifiers, 4:147-58 (1985).
Gravenstein, S., et al., Jags, 37:1-8 (1989).
Korba, B.E., et al., Hepatology, 12: Abs. 880 (1990).
Weiner, A.J., et al., Lancet 335:1-3 (1990).
Ulrich, P., et al., J. Clin. Invest., 86:1609-14 (1990).
Knodell, R. G. et al., Hepatology, 1:431-5 (1981).

Affiliated with

Also associated with

Rating

Composition and method of treating hepatitis C does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition and method of treating hepatitis C, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method of treating hepatitis C will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1457902